Back to Search Start Over

484PRetrospective RAS analysis of the EPIC trial: Cetuximab plus irinotecan vs irinotecan in patients (pts) with second-line metastatic colorectal cancer (mCRC).

Authors :
Sobrero, A
Lenz, H-J
Eng, C
Scheithauer, W
Middleton, G
Chen, W
Esser, R
Nippgen, J
Burris, H
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Subjects

Subjects :
*COLORECTAL cancer
*METASTASIS
*CETUXIMAB
*BRACHIAL plexus

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133286311
Full Text :
https://doi.org/10.1093/annonc/mdy281.032
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details